Steroid-refractory acute GvHD could not be controlled and we therefore decided to administer third-party MSCs (0.9 × 106 CD73+/CD105+ cells/kg of recipient weight, obtained from an unrelated female donor). This evidence concerns the gene ENG and graft versus host disease.